Drug interactions
Glimepiride-pioglitazone + Insulin degludec
Severity: Major
Glimepiride-pioglitazone and Insulin degludec: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Combining insulin with glimepiride and pioglitazone increases the risk of hypoglycemia. Insulin with pioglitazone also raises the risk of fluid retention, edema and heart failure.
What this interaction means in plain words
Glimepiride-pioglitazone and Insulin degludec can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Glimepiride-pioglitazone belongs to Endocrine; Insulin degludec belongs to Endocrine.
Why it happens
Additive glucose lowering, and thiazolidinedione-induced sodium and fluid retention is amplified by insulin.
What to do
Reduce insulin or sulfonylurea doses as needed and monitor glucose. Watch for weight gain, edema and heart failure symptoms, particularly in patients with cardiac risk.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Glimepiride-pioglitazone and Insulin degludec, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Glimepiride-pioglitazone
Other interactions of Insulin degludec
Frequently asked questions
Can I take Glimepiride-pioglitazone with Insulin degludec?
MediHelp rates the interaction as major. Glimepiride-pioglitazone and Insulin degludec can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Combining insulin with glimepiride and pioglitazone increases the risk of hypoglycemia. Insulin with pioglitazone also raises the risk of fluid retention, edema and heart failure.
How serious is the interaction between Glimepiride-pioglitazone and Insulin degludec?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce insulin or sulfonylurea doses as needed and monitor glucose. Watch for weight gain, edema and heart failure symptoms, particularly in patients with cardiac risk.
What other medicines interact with Glimepiride-pioglitazone?
MediHelp also lists interactions of Glimepiride-pioglitazone with, for example, Fluconazole, Gemfibrozil, Insulin aspart. The full list is on the Glimepiride-pioglitazone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
